Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [171]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationInfection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Self-citationValidation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Vu, T., Farish, S., Jenkins, M., & Kelly, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00041-5 · Cited by 376
Research works printed but not linked: 7
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford, England: Blackwell Science, 1998:358-72.
- Becher H, 2000, J Epidemiol Biostat, 5, 277
- 1999, MMWR Morb Mortal Wkly Rep, 48, 374
- 2000, MMWR Morb Mortal Wkly Rep, 49, 375
- 1997, MMWR Morb Mortal Wkly Rep, 46, 1
- Healthy People 2010: conference edition. Vol. 1. Washington, D.C.: Department of Health and Human Services, January 2000.
Cited by
Items 301–400 of 742
Charland, K., Buckeridge, D. L., Hoen, A. G., Berry, J. G., Elixhauser, A., Melton, F., & Brownstein, J. S. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12019 · Cited by 33
Annual revaccination against influenza and mortality risk in community-dwelling elderly persons
Voordouw, A. C. G., Sturkenboom, M., & Dieleman, J. P. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.065 · Cited by 31
Influenza virus and atherosclerosis
Peretz, A., Azrad, M., & Blum, A. (2018) · QJM · doi:10.1093/qjmed/hcy305 · Cited by 32
Ishigami, J., Sang, Y., Grams, M. E., Coresh, J., Chang, A. R., & Matsushita, K. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.09.008 · Cited by 35
Aïdoud, A., Marlet, J., Angoulvant, D., Debacq, C., Gavazzi, G., & Fougère, B. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.05.070 · Cited by 31
Repeated influenza vaccination of healthy children and adults: borrow now, pay later?
Carrat, F., Lavenu, A., Cauchemez, S., & Deleger, S. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805005479 · Cited by 34
“Vaccination reduces mortality of all causes in the elderly by 30-70 %, and prevents hospital admissions for influenza-related respiratory disease, heart disease and stroke [2-4].”
BackgroundATVB In Focus: Immunity and Atherosclerosis
Hansson, G. K. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000153139.83149.a2 · Cited by 30
Influenza Vaccination Coverage among Adults in Korea: 2008–2009 to 2011–2012 Seasons
Yang, H. J., & Cho, S. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph111212162 · Cited by 29
“Vaccination in high-risk groups, in particular, reduces morbidity and mortality [15–19].”
BackgroundImproving Outcomes of Elderly Patients with Community-Acquired Pneumonia
Gutiérrez, F., & Masiá, M. (2008) · Drugs & Aging · doi:10.2165/00002512-200825070-00005 · Cited by 34
Factors affecting repeated influenza vaccination among older people in Taiwan
Chang, Y.-C., Huang, N., Chen, L.-S., Hsu, S., & Chou, Y. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.086 · Cited by 30
Influenza and Pneumococcal Vaccinations Fail to Prevent Myocardial Infarction
Meyers, D. G., Beahm, D. D., Jurisich, P. D., Milford, C. J., & Edlavitch, S. A. (2004) · Heart Drug · doi:10.1159/000077705 · Cited by 29
Annual report of the National Influenza Surveillance Scheme, 1999
Thomson, J., Lin, M. M., & Hampson, A. W. (2000) · Communicable Diseases Intelligence · doi:10.33321/cdi.2000.24.22 · Cited by 29
Prevention of Nosocomial Pneumonia in the Intensive Care Unit: Beyond the Use of Bundles
Kollef, M. H. (2010) · Surgical Infections · doi:10.1089/sur.2010.060 · Cited by 28
“Appropriate use of influenza and pneumococcal vaccines is recommended to reduce the incidence of respiratory failure related to these infections, which could secondarily increase the occurrence of VAP [40,41].”
Epps, P. V., Tumpey, T. M., Pearce, M. B., Golding, H., Higgins, P. A., Hornick, T. R., Burant, C. J., Wilson, B. M., Banks, R. E., Gravenstein, S., et al. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00498-16 · Cited by 31
“among older adults (9, 10), the magnitude of mortality and morbidity benefits among older versus younger adults has been a source of debate (11, 12).”
BackgroundHerzog, N. S., Bratzler, D. W., Houck, P. M., Jiang, H., Nsa, W., Shook, C., & Weingarten, S. R. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00440-6 · Cited by 33
Atherosclerosis and Infection: Is the Jury Still Not In?
Chatzidimitriou, D., Kirmizis, D. A., Gavriilaki, E., Chatzidimitriou, M., & Malisiovas, N. (2012) · Future Microbiology · doi:10.2217/fmb.12.87 · Cited by 27
Livni, G., Chodik, G., Yaari, A., Tirosh, N., & Ashkenazi, S. (2015) · Journal of Pediatric Infectious Diseases · doi:10.1055/s-0035-1556979 · Cited by 27
“The optimal approach is prevention by an active vaccine [1].”
BackgroundCost–effectiveness analysis of influenza vaccination for people aged 65 and over in Japan
Hoshi, S., Kondo, M., Honda, Y., & Okubo, I. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.067 · Cited by 28
Does Sex Influence Immunization Status for Influenza and Pneumonia in Older Veterans?
Bean‐Mayberry, B., Yano, E. M., Mor, M. K., Bayliss, N. K., Xu, X., & Fine, M. J. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02316.x · Cited by 29
Sims, J. B., de Lemos, J. A., Maewal, P., Warner, J. J., Peterson, G., & McGuire, D. K. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.08.043 · Cited by 30
Novel strategies for prevention and treatment of influenza
Kandel, R., & Hartshorn, K. L. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.1 · Cited by 28
“Influenza vaccination also decreases hospitalisation due to heart disease and strokes in the elderly [18].”
BackgroundReducing medical service utilization by encouraging vaccines
Berg, G. D., Thomas, E., Silverstein, S. M., Neel, C. L., & Mireles, M. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.07.001 · Cited by 27
Hara, M., Sakamoto, T., & Tanaka, K. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.027 · Cited by 27
Racial/Ethnic Disparities in Influenza Vaccination Coverage Among US Adolescents, 2010-2016
Webb, N. S., Dowd-Arrow, B., Taylor, M. G., & Burdette, A. M. (2018) · Public Health Reports® · doi:10.1177/0033354918805720 · Cited by 26
“Compared with white adults, black and Hispanic adults have higher rates of cardiovascular disease, cerebrovascular disease, and diabetes— conditions that make contracting influenza particularly harmful.(28-33) Additional research is needed not only to increase influenza vaccination rates among all adolescents but also…”
BackgroundRoyo‐Bordonada, M. Á., Bejarano, J. M. L., Álvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Revista Española de Salud Pública · doi:10.4321/s1135-57272013000200002 · Cited by 37
Royo‐Bordonada, M. Á., Bejarano, J. M. L., Álvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2013.04.003 · Cited by 27
Haugh, M. C., Gresset-Bourgeois, V., Macabeo, B., Woods, A., & Samson, S. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1324302 · Cited by 29
“Health economics studies have shown that influenza vaccination, in general, is cost-effective, especially in the elderly or in at-risk population [121].”
BackgroundA Review of Vaccinations in Adult Patients with Secondary Immunodeficiency
Righi, E., Gallo, T., Azzini, A. M., Mazzaferri, F., Cordioli, M., Merighi, M., & Tacconelli, E. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00404-y · Cited by 28
OXFORD, J. S., Manuguerra, C. J., Kistner, O., Linde, A., Kunze, M., Lange, W., Schweiger, B., Spala, G., Rebelo‐de‐Andrade, H., Breña, P., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.10.053 · Cited by 26
“More recent data also indicates beneficial effect at preventing stroke and heart diseases [ 27 ] itself indicating that there is more to be discovered about the molecular pathology of influenza in humans including virus H5N1 [49].”
BackgroundSeo, Y. B., Hong, K., Kim, I. S., Choi, W. S., Baek, J. H., Lee, J., Song, J. Y., Lee, J. S., Cheong, H. J., & Kim, W. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.024 · Cited by 27
Maggi, S. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.26 · Cited by 27
Chen, C.-I., Kao, P., Wu, M., Fang, Y.-A., Miser, J. S., Liu, J., & Sung, L. (2016) · Medicine · doi:10.1097/md.0000000000002588 · Cited by 28
“Except for shared common etiologic factors between CKD and CAD (such as diabetes, hypertension, and dyslipidemia), the reduced renal function is associated with chronic inflammation, elevated plasma homocysteine, increased proinflammatory cytokines due to both increased production and decreased renal clearance, enhanc…”
BackgroundInfluentialMcElhaney, J. E., Andrew, M. K., & McNeil, S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.084 · Cited by 26
Saudi Heart Association (SHA) guidelines for the management of heart failure
AlHabeeb, W., Alayoubi, F., Alghalayini, K. W., Ghofaili, F. A., Hebaishi, Y. A., Al‐Jazairi, A. S., Al-Mallah, M. H., Almasood, A. S., Qaseer, M. A., AlSaif, S. M., et al. (2019) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2019.06.004 · Cited by 30
“Vaccinations against influenza are associated with a reduced risk of hospitalization due to heart disease, pneumonia, and influenza [153].”
BackgroundGil, H., Bailly, P., MÉAUX-RUAULT, N., Clement, I., Floret, N., Guiot, A., Manteaux, C., Talon, D. R., Magy-Bertrand, N., & Dupond, J. L. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.09.007 · Cited by 25
Kao, P., Liu, J., Hsu, Y.-P., Sung, L., Yang, T.-Y., Hao, W., Lin, Y., & Wu, S. (2017) · Oncotarget · doi:10.18632/oncotarget.22352 · Cited by 26
“Although studies have used a similar population of elderly patients,[13, 14] they did not focus on patients having a high risk of ischemic stroke (i.”
BackgroundResultVaccination Against Classical Influenza in Health-Care Workers
Wicker, S., Rabenau, H. F., Kempf, V. A. J., & Brandt, C. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0567 · Cited by 24
McElhaney, J. E., Herre, J. M., Lawson, M. L., Cole, S. K., Burke, B. L., & Hooton, J. W. L. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.08.032 · Cited by 28
Influenza A— associated stroke in a 4-year-old male
Bell, M. L., & Buchhalter, J. (2004) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2004.04.002 · Cited by 24
Ferdinands, J. M., Gargiullo, P. M., Haber, M., Moore, M. R., Belongia, E. A., & Shay, D. K. (2013) · Epidemiology · doi:10.1097/ede.0b013e3182953065 · Cited by 23
Boonnak, K., Dhitavat, J., Thantamnu, N., Kosoltanapiwat, N., Auayporn, M., Jiang, L., Puthavathana, P., & Pitisuttithum, P. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.10.106 · Cited by 28
Nursing Home–Associated Pneumonia
Mylotte, J. M. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.02.003 · Cited by 23
Prevention and Control of Influenza
Lee, P. P. (2003) · Southern Medical Journal · doi:10.1097/01.smj.0000084985.13843.89 · Cited by 24
“Recently, an observational study demonstrated that TIIV in two large elderly patient cohorts was associated with substantial reductions in the risk of hospitalization for cardiac disease (19%) and cerebrovascular accident (16–23%).(28) Of significance, and perhaps the most impressive result of this meta-analysis, howe…”
Nichol, K. L., Nordin, J. D., & Mullooly, J. P. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.10.004 · Cited by 24
Self-citationCoenzyme Q10 in acute influenza
Chase, M., Cocchi, M. N., Liu, X., Andersen, L. W., Holmberg, M. J. J., & Donnino, M. W. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12608 · Cited by 23
Choe, Y. J., Cho, H., Kim, S. N., Bae, G., & Lee, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.129 · Cited by 22
Patra, P., Mondal, N., Patra, B. C., & Bhattacharya, M. (2019) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-019-09921-4 · Cited by 22
“Vaccination against the disease will be the finest and reliable option for controlling the disease outbreak (Nichol et al. 2003).”
BackgroundAjani, U. A., Ford, E. S., & Mokdad, A. H. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.028 · Cited by 22
Influenza Vaccination in the Elderly: Seeking New Correlates of Protection and Improved Vaccines
McElhaney, J. E. (2008) · Aging Health · doi:10.2217/1745509x.4.6.603 · Cited by 22
Pharmacists’ role in increasing pneumococcal and influenza vaccination
Sokos, D. R. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.4.0367 · Cited by 22
Emerging drugs for the treatment of chronic obstructive pulmonary disease
Malhotra, S., Man, S. F. P., & Sin, D. D. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.2.275 · Cited by 22
Treatment of pneumonia in elderly patients
Schmidt-Ioanas, M., & Lode, H. M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.5.499 · Cited by 22
“[53] showed that influenza vaccination reduces the risk of hospitalisation for pneumonia, stroke or cardiac cause.”
BackgroundVaccine responsiveness in the elderly: best practice for the clinic
Aspinall, R., & Lang, P. O. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.924403 · Cited by 26
Lam, F., Chen, T.-L., Shih, C.-C., Lin, C., Yeh, C.-C., Lee, Y., Hu, C., Chiou, H., & Liao, C. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.01.008 · Cited by 21
Pharmacotherapy of Lower Respiratory Tract Infections in Elderly—Focused on Antibiotics
Liu, Y., Zhang, Y., Zhao, W., Liu, X., Hu, F., & Dong, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01237 · Cited by 22
“Some standard-dose (SD) influenza vaccine studies among elderly have estimated benefits in preventing hospitalization and mortality due to pneumonia (Nichol et al., 2003; Nichol et al., 2007; Jansen et al., 2008) .”
BackgroundLack of Persistence of Influenza Vaccine Antibody Titers in Patients With Heart Failure
Albrecht, C. M., Sweitzer, N. K., Johnson, M. R., & Vardeny, O. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.12.008 · Cited by 23
Liu, W.-C., Lin, C., Yeh, C.-C., Wu, H.-Y., Lee, Y., Chung, C., Cherng, Y., Chen, T.-L., & Liao, C. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix616 · Cited by 21
“In addition, high rates of nosocomial influenza and pneumonia were reported in hospitalized patients [37, 38].”
Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China
Chen, Q., Wang, L., Xie, M., Li, X., & Recommendations for Influenza, S. P. V. I. E. P. I. C. W. G. (2020) · Aging Medicine · doi:10.1002/agm2.12102 · Cited by 21
Walzer, P., Estève, C., Barben, J., Menu, D., Cuenot, C., Manckoundia, P., & Putot, A. (2020) · Vaccines · doi:10.3390/vaccines8030356 · Cited by 24
“5 Charlson Comorbidity Index 5 [4,5] 5 [4,6] <0.”
BackgroundPolnaszek, B., Mirr, J., Roiland, R. A., Gilmore‐Bykovskyi, A. L., Hovanes, M., & Kind, A. (2015) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.07.013 · Cited by 25
Influenza and Acute Myocardial Infarction
Finelli, L., & Chaves, S. S. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir175 · Cited by 21
Lower respiratory tract infections: prevention using vaccines
Whitney, C. G., & Harper, S. A. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.07.008 · Cited by 22
“A recent large observational study of adults 65 years of age and older found that vaccination against influenza was associated with reduced risk for hospitalization for cardiac disease (19% reduction), cerebrovascular disease (16%–23% reduction), and pneumonia or influenza (29%–32% reduction), and a reduction in the r…”
BackgroundThe effect of infections and vaccinations on stroke risk
Grau, A. J., Marquardt, L., & Lichy, C. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.2.175 · Cited by 21
Vacinação do Cardiopata contra COVID-19: As Razões da Prioridade
Martins, W. D. A., de Oliveira, G. M. M., Brandão, A. A., Mourilhe‐Rocha, R., Mesquita, E. T., Saraiva, J. F. K., Bacal, F., & Lopes, M. A. C. Q. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210012 · Cited by 34
Montalescot, G., estable, G. D. T. D. L. S. E. D. C. S. D. Y. T. D. L. C. I., Sechtem, U. P., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.11.007 · Cited by 38
Models cannot predict future outbreaks: A/H1N1 virus, the paradigm
Nougaırède, A., Charrel, R. N., & Raoult, D. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9533-6 · Cited by 20
Strategies to maximize influenza vaccine impact in older adults
Whitaker, J. A., von Itzstein, M. S., & Poland, G. A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.040 · Cited by 21
Influence of Influenza Infection on In-Hospital Acute Myocardial Infarction Outcomes
Tripathi, B., Kumar, V. M., Kalra, A., Gupta, T., Sawant, A. C., Sharma, P., Arora, S., Panhwar, M. S., Gopalan, R. S., Deshmukh, A. J., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.05.045 · Cited by 20
Vacinação contra influenza e pneumococo na insuficiência cardíaca: uma recomendação pouco aplicada
Martins, W. D. A., Ribeiro, M. D., de Oliveira, L. B., de Barros, L. D. S. N., Jorge, A. C. D. S. M., dos Santos, C. M., Almeida, D. D. P., Cabral, I. F., de Souza, R. T., & Furquim, T. A. B. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011005000010 · Cited by 20
Respiratory Syncytial Virus Infection and Risk of Acute Myocardial Infarction
Guan, X. R., Jiang, L., Ma, X. H., Wang, L. F., Quan, H., & Li, H. Y. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181eecf29 · Cited by 20
Seo, Y. B., Choi, W. S., Baek, J. H., Lee, J., Song, J. Y., Lee, J. S., Cheong, H. J., & Kim, W. J. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26858 · Cited by 20
“Furthermore, 19–27% decrease in hospitalized due to CHF was also noted.(9) In another study, it was found that a reduction of 27% in hospitalization due to CHF after influenza vaccination.”
BackgroundRelationship between Supra-Annual Trends in Influenza Rates and Stroke Occurrence
Field, T. S., Zhu, H., Tarrant, M., Mitchell, J. R., & Hill, M. D. (2004) · Neuroepidemiology · doi:10.1159/000079948 · Cited by 20
Outpatient treatment of chronic obstructive pulmonary disease: Comparisons with asthma
Sutherland, E. R. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.044 · Cited by 21
Pneumonia in Older Adults: Reversing the Trend
File, T. M., & Tan, J. S. (2005) · JAMA · doi:10.1001/jama.294.21.2760 · Cited by 20
Influenza vaccine effect on risk of stroke occurrence: a systematic review and meta-analysis
Zahhar, J. A., Salamatullah, H. K., Almutairi, M. B., Faidah, D. E., Afif, L. M., Banjar, T., Alansari, N., Betar, M., Alghamdi, S., & Makkawi, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1324677 · Cited by 19
Influenza Vaccination for Secondary Prevention of Cardiovascular Events: A Systematic Review
LeBras, M. H., & Barry, A. R. (2017) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v70i1.1626 · Cited by 22
Zhang, H. T., McGrath, L. J., Wyss, R., Ellis, A. R., & Stürmer, T. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4298 · Cited by 20
“The individual components of Gagne et al's combined Charlson‐Elixhauser comorbidity score were assessed as represented in Table 2 of their paper(21) and supplemented with additional comorbidities controlled for in the literature.(2-4,6,8) These baseline comorbidities were defined using CPT, HCPCS, and ICD‐9‐ CM codes.”
MethodResultDecreased T‐Cell Responses to Influenza Vaccination in Patients with Heart Failure
Vardeny, O., Moran, J. J. M., Sweitzer, N. K., Johnson, M. R., & Hayney, M. S. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.10 · Cited by 20
“Vaccination against influenza infection decreases heart-related hospital admissions, acute CHF exacerbations, and all-cause mortality.(2) Despite widespread influenza vaccination programs, overall influenza-related hospitalizations and mortality rates are rising, particularly in patients with cardiac disease.”
BackgroundImpaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia
Loffredo, L., Cangemi, R., Perri, L., Catasca, E., Calvieri, C., Carnevale, R., Nocella, C., Equitani, F., Ferro, D., Violi, F., et al. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.09.008 · Cited by 18
Chen, H., Li, Q., Zhang, M., Gu, Z., Zhou, X., Cao, H., Wu, F., Liang, M., Zheng, L., Xian, J., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2133912 · Cited by 18
Cobertura vacinal está relacionada à menor mortalidade por doenças respiratórias
Bós, Â. J. G., & Mirandola, A. R. (2013) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232013000500031 · Cited by 18
Promoting Health and Wellbeing in Later Life
Staehelin, H. B. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511610714.016 · Cited by 24
Hebert, K. A., Marzouka, G. R., Arcement, L. M., Julian, E., Cortazar, F. B., Dias, A. M., & Tamariz, L. J. (2010) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2010.00190.x · Cited by 18
Influenza vaccination for healthcare workers: from a simple concept to a resistant issue?
Gavazzi, G. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324908 · Cited by 18
Tacken, M. A. J. B., Braspenning, J. C. C., Berende, A., Hak, E., de Bakker, D. H., Groenewegen, P., & Grol, R. P. T. M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.017 · Cited by 25
“reductions in the traditionally used endpoints, such as mortality and hospitalisation, were shown [11– 14].”
BackgroundMethodInactivated influenza vaccination for people with spinal cord injury
Trautner, B. W., Atmar, R. L., Hulstrom, A., & Darouiche, R. O. (2004) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.03.022 · Cited by 18
Rubin, M. S., Nivin, B., & Ackelsberg, J. (2008) · Clinical Infectious Diseases · doi:10.1086/588658 · Cited by 18
“Influenza can cause serious complications among elderly individuals, including pneumonia and exacerbation of underlying conditions that can result in hospitalization or death [1].”
BackgroundInfluenza and pneumococcal vaccination of the elderly in Taiwan
Chen, Y.-H., Liou, S., Chou, C.-C., Su, W., Loh, C., & Lin, S.-H. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.003 · Cited by 19
Liprandi, Á. S., Zaidel, E. J., López-Santi, R., Araujo, J. J., González, M. A. B., Busso, J. M., Cabral, L., Camilletti, J., Erriest, J., Flores, R., et al. (2021) · Vaccines · doi:10.3390/vaccines9020123 · Cited by 22
Mortality Spike at New Year but not Christmas in North East England
Milne, E. M. G. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-2147-8 · Cited by 17
“Cohort data from the US have demonstrated the substantial impact of influenza immunisation on respiratory and all-cause mortality [21].”
BackgroundInfluenza and Pneumococcal Vaccinations in the Emergency Department
Martin, D. R., Brauner, M. E., & Plouffe, J. F. (2008) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2008.02.004 · Cited by 18
“hospitalizations (all causes) by approximately 50%, the risk for pneumonia by approximately 60%, and the risk for death (all causes) by 68% [ 79 ] (Box 1, Table 1).”
BackgroundVacinação contra influenza em idosos por área de residência: prevalência e fatores associados
Francisco, P. M. S. B., Donalísio, M. R., Barros, M. B. D. A., César, C. L. G., Carandina, L., & Goldbaum, M. (2006) · Revista Brasileira de Epidemiologia · doi:10.1590/s1415-790x2006000200003 · Cited by 24
“Sexo Masculino 408 42,6 (39,2 - 46,0) 282 43,0 (39,7 - 46,3) Feminino 416 57,4 (53,2 - 61,6) 337 57,0 (53,4 - 60,6) Faixa etária 60 a 69 459 54,2 (49,7 - 58,8) 376 65,5 (60,6 - 70,4) 70 e mais 365 45,8 (41,6 - 49,9) 243 34,5 (30,1 - 38,9) Situação conjugal Com cônjuge 505 58,6 (54,4 - 62,8) 331 55,4 (51,1 - 59,8) Sem…”
Management standards for stable coronary artery disease in India
Mishra, S., Ray, S., Dalal, J. J., Sawhney, J. P. S., Ramakrishnan, S., Nair, T., Iyengar, S. S., & Bahl, V. K. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.11.320 · Cited by 18
Low Prevalence of Influenza Vaccination Among People with Cardiovascular Disease—BRFSS
Ajani, U. A., Ford, E. S., Okoro, C. A., Strine, T. W., Giles, W. H., & Mokdad, A. H. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.07.014 · Cited by 17
Pleiotropic Effects of Influenza Vaccination
Hjelholt, A. J., Bergh, C., Bhatt, D. L., Fröbert, O., & Kjølby, M. (2023) · Vaccines · doi:10.3390/vaccines11091419 · Cited by 18
Global burden of influenza lower respiratory tract infections in older people from 1990 to 2019
Feng, J., Zhao, H.-Y., & Zhan, S.-Y. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02553-1 · Cited by 17
“Notably, vaccine is the mainstay in preventing influenza LRTIs deaths in humans, which could reduce seasonal influenza outbreaks, complications of influenza [32], and can reduce 30% to 70% of hospitalization for pneumonia and influenza, and prevent 53% to 80% of death in older adults [1, 33].”
BackgroundKarve, S. J., Misurski, D. A., Herrera‐Taracena, G., & Davis, K. L. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0020-6 · Cited by 16
National availability of influenza vaccine among medical subspecialty practices
Davis, M. M., WORTLEY, P. M., Ndiaye, S. M., Woods, M. G., & Clark, S. J. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2003.12.016 · Cited by 16
Castilla, J., Etxeberria, J., Ardanáz, E., Floristán, Y., Escudero, R. L., & Guevara, M. (2010) · Eurosurveillance · doi:10.2807/ese.15.05.19481-en · Cited by 16
Akın, L., Macabeo, B., Çalışkan, Z., Altınel, S., & Satman, İ. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157657 · Cited by 19
Metadata
- Authors
- Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M.
- Affiliations
- University of Minnesota (US)
- HealthPartners (US)
- Kaiser Permanente (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Nordin, James
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1322-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116971894
- Cited by
- 752
- References
- 42
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 29 · 2013: 42 · 2012: 50
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza vaccination, influenza, stroke, heart disease, hospitalization, older adults, pneumonia, mortality, ischemic heart disease, cerebrovascular disease, upper respiratory tract infection, managed care, community-dwelling older adults, vaccine effectiveness, dementia, comorbidities, subgroup analysis
- MeSH terms
- Aged, Aged, 80 and over, Female, Heart Diseases, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Mortality, Pneumonia, Risk, Logistic Models, Odds Ratio, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.